Skip to main content
Filing year 2022

Endure to Cure Pediatric Cancer Foundation

Wilmington, Delaware·EIN 45-2861060·NTEE H129 · Medical Research·501(c)(3)
Total revenue
$250k
Total assets
$7k
Total expenses
$229k
Reported officers
4
Mission

Provide aid to pediatric cancer patients

Reported officers (all unpaid)

No paid executives reported in 2022. Endure to Cure Pediatric Cancer Foundation reported 4 unpaid officers and board members on its 990.

Director
Director
CEO
Treasurer

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Sector benchmark

What Medical Research executives earn

Endure to Cure Pediatric Cancer Foundation reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $120,264.

25th percentile
$48k
Median
$120,264
75th percentile
$252k
90th percentile
$466k

These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).

See full Medical Research compensation data
FAQ

Common questions about Endure to Cure Pediatric Cancer Foundation

What are Endure to Cure Pediatric Cancer Foundation's revenue and expenses?

In 2022, Endure to Cure Pediatric Cancer Foundation reported $250k in total revenue and $229k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.